NFKB1 and mucositis: Following cytotoxic therapy, the bound NF-κB/IκB is phosphorylated and ubiquitinated; then, NF-κB is allowed to enter the nucleus where it is able to up-regulate many genes associated with mucositis, including pro-inflammatory cytokines, growth factors, and pro- and antiapoptotic genes [16].